Insider sale: 148,750 shares filed for UTHR (NASDAQ: UTHR)

Rhea-AI Filing Summary

Reported sale of company stock under Rule 144 and a 10b5-1 plan. The filing shows 148,750 shares tied to an exercise of stock options dated 05/04/2026, with multiple prior 10b5-1 sales by James C. Edgemond of 10,000 shares per trade on several dates in March–April 2026 and proceeds listed for each trade.

Insights

Securities Compliance Analyst

Routine executed sales under a 10b5-1 plan and option exercise reported via Form 144.

The filing lists an exercise of stock options for 148,750 shares dated 05/04/2026, and shows multiple 10,000-share 10b5-1 sales by James C. Edgemond in March–April 2026 with per-trade cash proceeds recorded. This format aligns with standard disclosure for planned insider sales and subsequent resale notice requirements.

Cash‑flow treatment and ultimate purchaser details are not provided in the excerpt; subsequent SEC filings or broker confirmations would show completion status and any holding-period implications.

Key Figures

Shares tied to exercise: 148,750 shares Per-trade sale size: 10,000 shares Proceeds example — 04/30/2026: $5,726,061.75 +2 more

5 metrics

Shares tied to exercise 148,750 shares Exercise of stock options dated 05/04/2026

Per-trade sale size 10,000 shares Multiple 10b5-1 sales by James C. Edgemond (Mar–Apr 2026)

Proceeds example — 04/30/2026 $5,726,061.75 Proceeds from 10b5-1 sale of 10,000 shares on 04/30/2026

Proceeds example — 04/27/2026 $5,688,318.75 Proceeds from 10b5-1 sale of 10,000 shares on 04/27/2026

Proceeds example — 03/30/2026 $5,931,683.25 Proceeds from 10b5-1 sale of 10,000 shares on 03/30/2026

Key Terms

10b5-1, Exercise of Stock Options, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Common | 05/04/2026 | Exercise of Stock Options"

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	148750	84847000.00	43827686	05/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/04/2026	Exercise of Stock Options	Issuer			148750	05/04/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	04/30/2026	10000	5726061.75
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	04/27/2026	10000	5688318.75
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	04/23/2026	10000	5723438.00
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	04/20/2026	10000	5778606.50
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	04/16/2026	10000	5771764.25
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	04/13/2026	10000	5748801.25
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	04/09/2026	10000	5778759.25
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	04/06/2026	10000	5583999.50
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	04/02/2026	10000	5614984.00
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	03/30/2026	10000	5931683.25
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	03/26/2026	10000	5359004.75
10b5-1 Sales for JAMES C EDGEMOND 1000 SPRING ST SILVER SPRING MD 20910	Common	03/23/2026	10000	5274801.75

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does UTHR's Form 144 report show about recent insider sales?

It reports an option exercise and planned resale of 148,750 shares dated 05/04/2026. The filing also lists multiple 10b5-1 sales by James C. Edgemond of 10,000 shares each on dates in March–April 2026 with cash proceeds shown for each trade.

Who executed the 10b5-1 sales listed in the filing?

James C. Edgemond executed the listed 10b5-1 sales. The excerpt shows repeated entries of 10,000-share sales on specific dates in March and April 2026, each accompanied by the cash proceeds for that trade.

How many shares were sold per trade in the reported 10b5-1 transactions?

Each reported 10b5-1 transaction lists 10,000 shares sold. The filing lists a sequence of such 10,000-share trades on various dates between 03/23/2026 and 04/30/2026 with individual proceeds recorded.

Does the filing state how much cash was received from the 10b5-1 sales?

Yes; each 10b5-1 trade includes a cash proceeds figure. Examples include $5,726,061.75 for 04/30/2026 and $5,688,318.75 for 04/27/2026 as recorded in the excerpt.